no statement of use filed
on 08 Jan 2024
Last Applicant/ Owned by
523 Davis Drive
Morrisville
NC
27560
Serial Number
97169063 filed on 13th Dec 2021
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical preparations for targeting and destroying bacteria; pharmaceutical preparations for the treatment of antibiotic-resistant bacterial infections and microbiome-related disorders; pharmaceutical preparations for use in the field of engineered bacteriophage; pharmaceuticals designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, name Read More
Pharmaceutical preparations for targeting and destroying bacteria; pharmaceutical preparations for the treatment of antibiotic-resistant bacterial infections and microbiome-related disorders; pharmaceutical preparations for use in the field of engineered bacteriophage; pharmaceuticals designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, namely, cancer, autoimmune and inflammatory diseases namely, transplantation and delayed-type hypersensitivity, respiratory diseases, gastrointestinal diseases, cardiovascular and metabolic diseases, pathogen infections, musculoskeletal diseases, ophthalmologic and dermatologic diseases, genitourinary diseases, degenerative diseases, and orphan diseases
No 97169063
No Service/Collective Mark
No 53240-TM1002
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
08th Jan 2024 | ABANDONMENT - NO USE STATEMENT FILED |
08th Jan 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
06th Jun 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
11th Apr 2023 | PUBLISHED FOR OPPOSITION |
11th Apr 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
22nd Mar 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
07th Mar 2023 | EXAMINERS AMENDMENT -WRITTEN |
07th Mar 2023 | EXAMINERS AMENDMENT E-MAILED |
07th Mar 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
07th Mar 2023 | EXAMINER'S AMENDMENT ENTERED |